21 CFR § 556.370 - Lubabegron.

---
identifier: "/us/cfr/t21/s556.370"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 556.370 - Lubabegron."
title_number: 21
title_name: "Food and Drugs"
section_number: "556.370"
section_name: "Lubabegron."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "E"
subchapter_name: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_number: "556"
part_name: "TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 342, 360b, 371."
regulatory_source: "84 FR 32993, July 11, 2019, unless otherwise noted."
cfr_part: "556"
---


# 556.370 Lubabegron.

(a) *Acceptable daily intake (ADI).* The ADI for total residues of lubabegron is 3 micrograms per kilogram of body weight per day.

(b) *Tolerances.* The tolerances for lubabegron (marker residue) are:

(1) *Cattle.* (i) Liver (target tissue): 10 ppb.

(ii) Muscle: 3 ppb.

(iii) Kidney: 20 ppb.

(2) [Reserved]

(c) *Related conditions of use.* See § 558.330 of this chapter.

[84 FR 12494, Apr. 2, 2019, as amended at 87 FR 17947, Mar. 29, 2022]